Effects of the HIV‐1 Viral Protein TAT on Central Neurotransmission: Role of Group I Metabotropic Glutamate Receptors

Brake, 1990, Identification of an Arg‐Gly‐Asp (RDG) cell adhesion site in human immunodeficiency virus type 1 transactivation protein Tat, J. Cell Biol., 111, 1275, 10.1083/jcb.111.3.1275 Chandra, 2005, Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N‐methyl‐D‐aspartate receptor subunits, Neuroscience, 134, 145, 10.1016/j.neuroscience.2005.02.049 Cheng, 1998, Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein, Neuroscience, 82, 97, 10.1016/S0306-4522(97)00174-7 Conn, 1997, Pharmacology and functions of metabotropic glutamate receptors, Annu. Rev. Pharmacol. Toxicol., 37, 205, 10.1146/annurev.pharmtox.37.1.205 Diesing, 2002, HIV‐1‐associated dementia: A basic science and clinical perspective, AIDS Read., 12, 358 Dingledine, 1999, The glutamate receptor ion channels, Pharmacol. Rev., 51, 7 Ensoli, 1993, Release, uptake and effects of extracellular HIV‐1 tat protein on cell growth in viral transactivation, J. Virol., 67, 277, 10.1128/JVI.67.1.277-287.1993 Everall, 1999, Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder, Brain Pathol., 9, 209, 10.1111/j.1750-3639.1999.tb00219.x Feligioni, 2003, The human immunodeficiency virus‐1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species‐specific mechanisms, J. Neurosci., 23, 6810, 10.1523/JNEUROSCI.23-17-06810.2003 Ghersi, 2003, Pharmacological heterogeneity of release‐regulating presynaptic AMPA/kainate receptors in the rat brain: Study with receptor antagonists, Neurochem. Int., 42, 283, 10.1016/S0197-0186(02)00129-8 Green, 1988, Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans‐activator protein, Cell, 55, 1179, 10.1016/0092-8674(88)90262-0 Haughey, 1999, Involvement of inositol 1,4,5‐trisphospahte‐regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV‐1 protein Tat, J. Neurochem., 73, 1363, 10.1046/j.1471-4159.1999.0731363.x Haughey, 2001, HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity, J. Neurochem., 78, 457, 10.1046/j.1471-4159.2001.00396.x Jones, 1996, Integrins: Possible functions in the adult CNS, Trends Neurosci., 19, 68, 10.1016/0166-2236(96)89623-8 Kelly, 1998, Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells, AIDS, 12, 1753, 10.1097/00002030-199814000-00006 Kolson, 1993, HIV‐1 Tat alters normal organization of neurones and astrocytes in primary rodent brain cell cultures: RDG sequence dependence, AIDS Res. Hum. Retroviruses, 9, 677, 10.1089/aid.1993.9.677 Kruman, 1998, HIV‐1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress, Exp. Neurol., 154, 276, 10.1006/exnr.1998.6958 Lawrence, 2002, HIV‐1 and the brain: Connections between HIV‐1‐associated dementia, neuropathology and neuroimmunology, Microbes Infect., 4, 301, 10.1016/S1286-4579(02)01542-3 Longordo, 2006, The human immunodeficiency virus‐1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons, J. Pharmacol. Exp. Ther., 317, 1097, 10.1124/jpet.105.099630 Magnuson, 1995, Human immunodeficiency virus type 1 Tat activates non‐N‐methyl‐d‐aspartate excitatory amino acid receptors and causes neurotoxicity, Ann. Neurol., 37, 373, 10.1002/ana.410370314 Masliah, 1992, Spectrum of human immunodeficiency virus‐associated neocortical damage, Ann. Neurol., 32, 321, 10.1002/ana.410320304 Masliah, 1996, Pathogenesis of HIV‐1 associated neurodegeneration, Crit. Rev. Neurobiol., 10, 57, 10.1615/CritRevNeurobiol.v10.i1.30 Masliah, 1997, Dendritic injury is a pathological substrate for human immunodeficiency virus‐related cognitive disorders, Ann. Neurol., 42, 963, 10.1002/ana.410420618 McArthur, 2004, HIV‐1 dementia: An evolving disease, J. Neuroimmunol., 157, 3, 10.1016/j.jneuroim.2004.08.042 McArthur, 1993, Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study, Neurology, 43, 2245, 10.1212/WNL.43.11.2245 McArthur, 2005, Neurological complications of HIV infection, Lancet Neurol., 4, 543, 10.1016/S1474-4422(05)70165-4 Mela, 2006, Group‐II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q‐type high voltage activated Ca2+ channels and endogenous dopamine, Mol. Cell. Neurosci., 31, 284, 10.1016/j.mcn.2005.09.016 Minghetti, 2004, Multiple actions of the human immunodeficiency virus type‐1 Tat protein on microglial cell functions, Neurochem. Res., 29, 965, 10.1023/B:NERE.0000021241.90133.89 Mothet, 1998, Cyclic ADP‐ribose and calcium‐induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia, J. Physiol., 507, 405, 10.1111/j.1469-7793.1998.405bt.x Nath, 1998, Neurobiological aspects of HIV infections: Neurotoxic mechanisms, Prog. Neurobiol., 54, 19, 10.1016/S0301-0082(97)00053-1 Nath, 1996, Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic, J. Virol., 70, 1475, 10.1128/JVI.70.3.1475-1480.1996 Navia, 1986, The AIDS dementia complex: I. Clinical features, Ann. Neurol., 19, 517, 10.1002/ana.410190602 Peruzzi, 2005, Cross talk between growth factors and viral and cellular factors alters neuronal signalling pathways: Implication for HIV‐associated dementia, Brain Res. Brain Res. Rev., 50, 114, 10.1016/j.brainresrev.2005.05.002 Pittaluga, 1990, Release‐enhancing glycine‐dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus, Eur. J. Pharmacol., 191, 231, 10.1016/0014-2999(90)94153-O Pittaluga, 1994, HIV‐1 envelope protein gp120 potentiates NMDA‐evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings, Eur. J. Neurosci., 6, 1743, 10.1111/j.1460-9568.1994.tb00566.x Pittaluga, 1997, Differential desensitization of ionotropic non‐NMDA receptors having distinct neuronal location and function, Naunyn Schmiedeberg's Arch. Pharmacol., 356, 29, 10.1007/PL00005025 Pittaluga, 2001, N‐methyl‐d‐aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV‐1 envelope protein gp120, external pH and protein kinase C inhibition, J. Neurochem., 76, 139, 10.1046/j.1471-4159.2001.00057.x Pittaluga, 2005, Extracellular protons differentially potentiate the responses of native AMPA receptors subtypes regulating neurotransmitter release, Br. J. Pharmacol., 144, 293, 10.1038/sj.bjp.0705960 Prendergast, 2002, Neurotoxic effects of the human immunodeficiency virus type‐1 transcription factor Tat require function of a polyamine sensitive‐site on the N‐methyl‐d‐aspartate receptor, Brain Res., 954, 300, 10.1016/S0006-8993(02)03360-7 Raiteri, 1974, A simple apparatus for studying the release of neurotransmitters from synaptosomes, Eur. J. Pharmacol., 25, 411, 10.1016/0014-2999(74)90272-6 Raiteri, 1992, N‐Methyl‐D‐aspartic acid (NMDA) and non‐NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal, J. Pharmacol. Exp. Ther., 260, 238 Rosenmund, 1998, The tetrameric structure of a glutamate receptor channel, Science, 280, 1596, 10.1126/science.280.5369.1596 Sabatier, 1991, Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1, J. Virol., 65, 961, 10.1128/JVI.65.2.961-967.1991 Salter, 2004, Src kinases: A hub for NMDA receptor regulation, Nat. Rev. Neurosci., 5, 317, 10.1038/nrn1368 Self, 2003, The human immunodeficiency virus type‐1 transcription factor Tat produces elevation in intracellular Ca2+ that requires function of an N‐methyl‐d‐aspartate receptor polyamine‐sensitive site, Brain Res., 995, 39, 10.1016/j.brainres.2003.09.052 Song, 2003, Human immunodeficiency virus type 1 Tat protein directly activates neuronal N‐methyl‐d‐aspartate receptors at an allosteric zinc‐sensitive site, J. Neurovirol., 9, 399, 10.1080/13550280390201704 Ungvarski, 2000, Neurocognitive disorders seen in HIV‐1 disease, Issues Ment. Health Nurs., 21, 51, 10.1080/016128400248266 Wang, 1999, Tat, a human immunodeficiency virus‐1‐derived protein, augments excitotoxic hippocampal injury in neonatal rats, Neuroscience, 88, 585, 10.1016/S0306-4522(98)00242-5 Wessenligh, 1993, Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia, Ann. Neurol., 33, 576, 10.1002/ana.410330604 Westendorp, 1995, Sensitization of T cells to CD95‐mediated apoptosis by HIV‐1 Tat and gp120, Nature, 375, 497, 10.1038/375497a0 Wiley, 1996, Expression of regulatory and structural mRNA in the central nervous system, AIDS, 10, 943, 10.1097/00002030-199607000-00007